Recombinant IL13 (Lebrikizumab Biosimilar) 抗体
Research Grade
适用: 人
ELISA
宿主: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- 抗原
- IL13 (Lebrikizumab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- 人
- 宿主
-
Mammalian Cells
- Expression System
- Mammalian cells
- 克隆类型
- 单克隆
- 应用范围
- ELISA
- 原理
- Lebrikizumab Biosimilar - Anti-IL13 mAb
- 产品特性
- Antibody Type: IgG4-kappa
- 纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
- 质量等级
- Research Grade
- 亚型
- IgG4 kappa
-
- 限制
- 仅限研究用
-
- 缓冲液
- PBS pH 7.5
- 储存条件
- -80 °C
- 储存方法
- store at -80°C
-
- 抗原
- IL13 (Lebrikizumab Biosimilar)
- 物质类
- Biosimilar
- 背景
-
MILR1444A,PRO301444
Lebrikizumab is a humanized monoclonal antibody targeting IL13, it is an experimental immunosuppressive drug for the treatment of asthma that cannot be adequately controlled with inhalable glucocorticoids. - CAS-编号
- 953400-68-5
-
You are here:
